Nucryst Pharmaceuticals Corp.

NUCRYST Announces Special Meeting of Shareholders.
Biotech Week; 12/9/2009; 714 words; NUCRYST Pharmaceuticals Corp. announced that...Keywords: Nucryst Pharmaceuticals Corporation, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, Nucryst Pharmaceuticals Corp. This article was...

NUCRYST announces 2009 third quarter financial results.(Financial report)
Biotech Week; 12/2/2009; 1092 words; ...Nanotech, Nanotechnology, Technology, Inflammation, Nucryst Pharmaceuticals Corporation, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, Nucryst Pharmaceuticals Corp. This article was prepared by Biotech Week editors...

Westaim announces 2009 third quarter results.(Financial report)
Biotech Week; 12/2/2009; 893 words; ...held by its 75 per cent owned subsidiary, NUCRYST Pharmaceuticals Corp., was $24.2 million. Westaim recently...execution of an amalgamation agreement with NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS). Under the...

FORM 8-K: NUCRYST PHARMACEUTICALS ANNOUNCES FINANCIAL STATEMENTS, EXHIBITS
US Fed News Service, Including US State News; 11/26/2009; 530 words; WASHINGTON, Nov. 25 -- NUCRYST PHARMACEUTICALS CORP., Princeton, N.J., files Form 8-K...of registrant as specified in its charter is NUCRYST PHARMACEUTICALS CORP. State of Incorporation: Canada Other Events...

NUCRYST Announces Agreement to Sell Acticoat Business and Proposes Amalgamation with Westaim.
Biotech Week; 11/25/2009; 1192 words; ...amalgamation agreement will be included in Nucryst's management information circular...as proposed or at all. Keywords: Nucryst Pharmaceuticals Corp., Nucryst Pharmaceuticals Corporation, Pharmaceutical Business, Pharmaceutical Company...